SCHEMBL16451653

SCHEMBL16451653

CCC[C@@H](O)c1cccc(C#CCOc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.45
ALOX5 P09917 5/20 0.42
MAPK1 P28482 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
MEN1 O00255 1/20 0.40
GMNN O75496 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233685 0.87 CA12 (0.42) KCNH2ALOX5KMT2ACA12CA1
SCHEMBL16451655 0.85 NPC1 (0.37) KCNH2ALOX5KMT2ACYP1A2CYP3A4
SCHEMBL13981324 0.81 KCNH2 (0.51) KCNH2ALOX5TSHRALDH1A1LMNA
SCHEMBL15461605 0.80 FFAR1 (0.43) KCNH2KMT2ALMNAEGFR
SCHEMBL2754739 0.79 MMP2 (0.47) KMT2AALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL10657949 0.75 MMP2 (0.47) ALOX5MAPK1KMT2ATP53CYP1A2
SCHEMBL14402624 0.75 PTGS1 (0.54) ALOX5MAPK1KMT2ATP53CYP1A2
SCHEMBL13850053 0.75 PTGS1 (0.54) ALOX5MAPK1KMT2ATP53CYP1A2
SCHEMBL4568897 0.74 LMNA (0.49) ALOX5MAPK1KMT2ATP53CYP1A2
SCHEMBL15461610 0.74 KMT2A (0.35) KMT2ATP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464033-B2 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders ACUCELA INC. (US) 2016-10-11 US disclosed
US-20150045444-A1 ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA INC. 2015-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045444-A1 ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS PDE6D, STARD3, PDE6C KCNH2 2318/4885ALOX5 341/4885MAPK1 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.